Marc Loriaux
Impact in
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 65
- Chronic Myeloid Leukemia Treatments 38
- Acute Myeloid Leukemia Research 31
- Genetics 53
- Chronic Lymphocytic Leukemia Research 38
- Myeloproliferative Neoplasms: Diagnosis and Treatment 16
- Co-authors
- Brian J. Druker (69 shared papers)Michael W. Deininger (35 shared papers)Jeffrey Tyner (55 shared papers)Anupriya Agarwal (17 shared papers)Amie S. Corbin (8 shared papers)Jörge E. Cortes (3 shared papers)Bill H. Chang (17 shared papers)Richard H. Goodman (3 shared papers)
- Journals
- Blood (47 papers)Leukemia (7 papers)Journal of Vascular and Interventional Radiology (6 papers)Cancer Cell (5 papers)Cancer Research (4 papers)
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Marc Loriaux
110 papers receiving 8.6k citations
Marc Loriaux's Hit Papers
Peers
Comparison fields: 5 of 118
- Hematology 4.3k
- Genetics 3.1k
- Rheumatology 904
- Cancer Research 871
- Oncology 1.4k
Countries citing papers authored by Marc Loriaux
This map shows the geographic impact of Marc Loriaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Loriaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Loriaux more than expected).
Fields of papers citing papers by Marc Loriaux
This network shows the impact of papers produced by Marc Loriaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Loriaux. The network helps show where Marc Loriaux may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Loriaux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance Hit paper breakdown → | 2009 | 1045 |
| 2 | Functional genomic landscape of acute myeloid leukaemia Hit paper breakdown → | 2018 | 997 |
| 3 | CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability Hit paper breakdown → | 2010 | 658 |
| 4 | Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity Hit paper breakdown → | 2010 | 652 |
| 5 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2019 | 549 |
| 6 | OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML Hit paper breakdown → | 2013 | 451 |
| 7 | 2006 | 278 | |
| 8 | Integrative analysis of drug response and clinical outcome in acute myeloid leukemia Hit paper breakdown → | 2022 | 251 |
| 9 | 2011 | 242 | |
| 10 | 2010 | 205 | |
| 11 | 1991 | 200 | |
| 12 | 2006 | 170 | |
| 13 | 2007 | 169 | |
| 14 | 2012 | 141 | |
| 15 | 2012 | 123 | |
| 16 | 2011 | 121 | |
| 17 | 2008 | 111 | |
| 18 | 2009 | 103 | |
| 19 | 2015 | 103 | |
| 20 | 2013 | 101 |
About Marc Loriaux
Marc Loriaux is a scholar working on Hematology, Genetics, Rheumatology, Oncology and Immunology, having authored 115 papers that have together received 8.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (38 papers), Chronic Myeloid Leukemia Treatments (38 papers), Acute Myeloid Leukemia Research (31 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Eosinophilic Disorders and Syndromes (16 papers), Acute Lymphoblastic Leukemia research (13 papers), Protein Degradation and Inhibitors (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Hematology (4.3k citations), Genetics (3.1k citations), Rheumatology (904 citations), Cancer Research (871 citations) and Oncology (1.4k citations). Marc Loriaux has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Brian J. Druker, Michael W. Deininger, Jeffrey Tyner, Anupriya Agarwal, Amie S. Corbin, Jörge E. Cortes, Bill H. Chang, Richard H. Goodman, Robert P. Rehfuss and Christopher A. Eide. Their work appears in journals such as Blood, Leukemia, Journal of Vascular and Interventional Radiology, Cancer Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.